New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position
- PMID: 9719605
- DOI: 10.1021/jm9802416
New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position
Abstract
We report an expansion of the scope of our initial discovery that 5-keto-substituted 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofurans (DHDMBFs) are antiinflammatory and analgesic agents. Several other functional groups have been introduced at the 5 position: amides, amidines, ureas, guanidines, amines, heterocycles, heteroaromatics, and heteroaryl ethenyl substituents in the 5 position all provide active compounds. These compounds are dual cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) inhibitors. They inhibit both COX-1 and COX-2 with up to 33-fold selectivity for COX-2.
Similar articles
-
New cyclooxygenase-2/5-lipoxygenase inhibitors. 2. 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations of the dihydrobenzofuran ring.J Med Chem. 1998 Mar 26;41(7):1124-37. doi: 10.1021/jm970680p. J Med Chem. 1998. PMID: 9544212
-
New cyclooxygenase-2/5-lipoxygenase inhibitors. 1. 7-tert-buty1-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: discovery and variation of the 5-keto substituent.J Med Chem. 1998 Mar 26;41(7):1112-23. doi: 10.1021/jm970679q. J Med Chem. 1998. PMID: 9544211
-
Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.J Med Chem. 1999 Apr 8;42(7):1151-60. doi: 10.1021/jm9805081. J Med Chem. 1999. PMID: 10197959
-
Cox-2-selective inhibitors: the new super aspirins.Mol Pharmacol. 1999 Apr;55(4):625-31. Mol Pharmacol. 1999. PMID: 10101019 Review. No abstract available.
-
[Clinical application of cyclooxygenase-2 inhibitors].Pol Merkur Lekarski. 2001 Jun;10(60):480-2. Pol Merkur Lekarski. 2001. PMID: 11503270 Review. Polish.
Cited by
-
Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors.J Comput Aided Mol Des. 2012 Nov;26(11):1217-28. doi: 10.1007/s10822-012-9611-9. Epub 2012 Sep 30. J Comput Aided Mol Des. 2012. PMID: 23053738
-
Dynamic simulations on the arachidonic acid metabolic network.PLoS Comput Biol. 2007 Mar 23;3(3):e55. doi: 10.1371/journal.pcbi.0030055. Epub 2007 Feb 7. PLoS Comput Biol. 2007. PMID: 17381237 Free PMC article.
-
Domino C-C/C-O bond formation: palladium-catalyzed regioselective synthesis of 7-iodobenzo[b]furans using 1,2,3-triiodobenzenes and benzylketones.RSC Adv. 2021 Sep 8;11(48):30069-30077. doi: 10.1039/d1ra05730h. eCollection 2021 Sep 6. RSC Adv. 2021. PMID: 35493993 Free PMC article.
-
Rationally designed multitarget agents against inflammation and pain.Curr Med Chem. 2013;20(13):1783-99. doi: 10.2174/0929867311320130013. Curr Med Chem. 2013. PMID: 23410172 Free PMC article. Review.
-
Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2.World J Gastroenterol. 2008 Apr 28;14(16):2494-500. doi: 10.3748/wjg.14.2494. World J Gastroenterol. 2008. PMID: 18442195 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials